Print E-mail Contact us
Company News
HD Biosciences Hosted Opening Ceremony for New Operation Facility in Zhang Jiang Hi-Tech Park in Shanghai
Shanghai, China C Oct 21, 2016
HD Biosciences Co., Ltd. (HDB), a leading biology-focused preclinical Contract Research Organization (CRO), held an unveiling ceremony for the grand opening of company's new state-of-the-art drug R&D service facility on Friday, 21st of October, 2016. The facility is located on 131 Kaiqing Road at Zhangjiang Hi-Tech Park, Shanghai, China and is adjacent to company's current main campus. Close
to 100 guests from pharmaceutical industry, government authorities and life science
technology companies attended the event.
HDB currently operates in both Zhangjiang Hi-Tech Park and La Jolla, California, USA. As part of expansion plan, the facility adds additional 50,000 square feet (SF) space, bringing the company total space to 150,000 SF. The new facility will house HDB's global "Center of the Excellence for HitID and Lead Discovery". The main laboratories are designed with total dust, humidity and temperature control. The enviroment is fully compliant with high standard operation for both 1536 and 384-well assay and screening. The annual output will increase from current 20 million datapoints to 50 million. Additionally, the new facility will also house HDB Tumor Cell Panel Profiling Center with collections of over 1,000 tumor
cell lines with genome database support and matching assay and screening capability.
"This expansion and investment further demonstrate HDB's commitment to build high standard, focused, science and technology driven drug R&D services, and to position the company towards a global leading player in CRO industry." Dr. Xuehai Tan, President and
CEO, commented.
HD Biosciences (China) Co.,Ltd
590 Ruiqing Road
Zhangjiang East Campus, Pudong, Shanghai 201201,
Tel: +86 (21) 5116 3700
Fax: +86 (21) 5116 3766
[email protected]